Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod159

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod159
Module size 46 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
91

ACVR1B activin A receptor type 1B
93

ACVR2B activin A receptor type 2B
94

ACVRL1 activin A receptor like type 1
268

AMH anti-Mullerian hormone
269

AMHR2 anti-Mullerian hormone receptor type 2
300016

BAMBI secreted Ly6/Plaur domain containing 1
27302

BMP10 bone morphogenetic protein 10
650

BMP2 bone morphogenetic protein 2
652

BMP4 bone morphogenetic protein 4
653

BMP5 bone morphogenetic protein 5
654

BMP6 bone morphogenetic protein 6
655

BMP7 bone morphogenetic protein 7
353500

BMP8A bone morphogenetic protein 8a
656

BMP8B bone morphogenetic protein 8b
168667

BMPER BMP binding endothelial regulator
657

BMPR1A bone morphogenetic protein receptor type 1A
658

BMPR1B bone morphogenetic protein receptor type 1B
659

BMPR2 bone morphogenetic protein receptor type 2
9350

CER1 cerberus 1, DAN family BMP antagonist
117275

CHRD chordin
91851

CHRDL1 chordin like 1
25884

CHRDL2 chordin like 2
10468

FST follistatin
11167

FSTL1 follistatin like 1
8200

GDF5 growth differentiation factor 5
392255

GDF6 growth differentiation factor 6
151449

GDF7 growth differentiation factor 7
26585

GREM1 gremlin 1, DAN family BMP antagonist
64388

GREM2 gremlin 2, DAN family BMP antagonist
3623

INHA inhibin subunit alpha
3624

INHBA inhibin subunit beta A
3625

INHBB inhibin subunit beta B
3626

INHBC inhibin subunit beta C
83729

INHBE inhibin subunit beta E
1482

NKX2-5 NK2 homeobox 5
4838

NODAL nodal growth differentiation factor
9241

NOG noggin
23645

PPP1R15A protein phosphatase 1 regulatory subunit 15A
56963

RGMA repulsive guidance molecule BMP co-receptor a
285704

RGMB repulsive guidance molecule BMP co-receptor b
4090

SMAD5 SMAD family member 5
4091

SMAD6 SMAD family member 6
4093

SMAD9 SMAD family member 9
25928

SOSTDC1 sclerostin domain containing 1
57045

TWSG1 twisted gastrulation BMP signaling modulator 1
9765

ZFYVE16 zinc finger FYVE-type containing 16

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
3.40e-01 7.18e-08 Reactome Antagonism of Activin by Follistatin

Signal Transduction
2.97e-01 1.39e-41 Reactome Signaling by BMP

Signal Transduction
2.75e-01 2.20e-17 GO BMP receptor binding

molecular_function
1.85e-01 5.48e-14 GO BMP binding

molecular_function
1.23e-01 2.32e-69 GO BMP signaling pathway

biological_process
1.09e-01 1.61e-46 GO positive regulation of pathway-restricted SMAD protein phosphorylation

biological_process
6.89e-02 1.57e-09 GO transforming growth factor beta receptor activity, type I

molecular_function
5.37e-02 3.67e-37 GO transforming growth factor beta receptor binding

molecular_function
3.70e-02 6.25e-07 GO morphogen activity

molecular_function
2.42e-02 5.95e-33 GO cell development

biological_process
1.93e-02 1.09e-42 Reactome Signaling by TGF-beta family members

Signal Transduction
1.15e-02 2.83e-32 GO regulation of MAPK cascade

biological_process
8.83e-03 1.47e-19 GO activin receptor signaling pathway

biological_process
5.21e-03 5.82e-11 GO mesoderm formation

biological_process

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
0e+00 0e+00 enzyme linked receptor protein signaling pathway

0e+00 0e+00 negative regulation of BMP signaling pathway

0e+00 0e+00 regulation of BMP signaling pathway

0e+00 0e+00 regulation of pathway-restricted SMAD protein phosphorylation

0e+00 0e+00 response to growth factor

0e+00 0e+00 cellular response to BMP stimulus

0e+00 0e+00 cellular response to growth factor stimulus

0e+00 0e+00 BMP signaling pathway

0e+00 0e+00 transmembrane receptor protein serine/threonine kinase signaling pathway

0e+00 0e+00 cartilage development

0e+00 0e+00 positive regulation of pathway-restricted SMAD protein phosphorylation

0e+00 0e+00 activin receptor signaling pathway

0e+00 0e+00 SMAD protein signal transduction

0e+00 0e+00 cytokine activity

0e+00 0e+00 cytokine receptor binding

0e+00 0e+00 transforming growth factor beta receptor binding

0e+00 0e+00 transmembrane receptor protein serine/threonine kinase activity

0e+00 0e+00 growth factor activity

0e+00 0e+00 BMP receptor binding

0e+00 0e+00 receptor serine/threonine kinase binding


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
0.00e+00 0.00e+00 SIGNALING BY BMP
0.00e+00 0.00e+00 SIGNALING BY BMP
2.04e-10 5.39e-08 GLYCOPROTEIN HORMONES
2.39e-10 6.28e-08 PEPTIDE HORMONE BIOSYNTHESIS
3.25e-08 8.94e-06 GLYCOPROTEIN HORMONES
4.11e-08 1.11e-05 PEPTIDE HORMONE BIOSYNTHESIS
1.72e-05 3.16e-03 SIGNALING BY NODAL
2.75e-05 3.83e-03 SIGNALING BY NODAL
2.04e-03 1.89e-01 NETRIN1 SIGNALING
6.59e-03 5.21e-01 METABOLISM OF AMINO ACIDS AND DERIVATIVES
9.10e-03 7.43e-01 DEVELOPMENTAL BIOLOGY
1.12e-02 8.71e-01 METABOLISM OF AMINO ACIDS AND DERIVATIVES
1.23e-02 9.39e-01 NETRIN1 SIGNALING
2.49e-02 1.00e+00 DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING
2.98e-02 1.00e+00 TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
3.89e-07 4.28e-03 abnormal pectoral muscle morphology

5.38e-06 3.11e-02 failure of primitive streak formation

1.35e-05 5.72e-02 decreased rib number

2.87e-05 9.93e-02 abnormal foregut morphology

3.23e-05 1.07e-01 absent mesoderm

6.07e-05 1.62e-01 hydroureter

7.54e-05 1.87e-01 abnormal extraembryonic ectoderm morphology

9.21e-05 2.14e-01 increased ovary weight

1.83e-04 3.30e-01 abnormal cricoid cartilage morphology

2.30e-04 3.79e-01 abnormal thyroid cartilage morphology

4.37e-04 5.60e-01 absent lower incisors

5.70e-04 6.57e-01 abnormal vertebral spinous process morphology

5.71e-04 6.58e-01 absent atrioventricular cushions

5.78e-04 6.61e-01 fused phalanges

1.14e-03 9.71e-01 abnormal skeleton morphology

1.29e-03 1.00e+00 abnormal heart position or orientation

1.29e-03 1.00e+00 abnormal vertebral arch development

1.34e-03 1.00e+00 male pseudohermaphroditism

1.37e-03 1.00e+00 abnormal hard palate morphology

1.45e-03 1.00e+00 increased skeletal muscle weight


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:27:36 2018 - R2HTML